For patients with early-stage renal cell carcinomas (RCCs) that measure between 3 and 4 centimeters, a procedure that destroys the cancer by freezing—called cryoablation—yields a lower-risk of cancer-related death compared ...
Nov 29, 2022
0
2
A study in the Journal of The National Cancer Institute Cancer Spectrum looked at chatbots and artificial intelligence (AI), as they become popular resources for cancer information. They found these resources give accurate ...
Mar 18, 2023
0
24
Researchers from the Medway School of Pharmacy (MSOP)—a partnership between the universities of Kent and Greenwich—in collaboration with colleagues from Inselspital (University Hospital of Bern, Switzerland) and the University ...
Jan 12, 2023
0
14
Obesity has been previously linked to an increased risk of cancer, but most studies have not differentiated the risks between male and female patients. A new study published June 12 in the journal Cancer Cell takes a closer ...
Jun 12, 2023
0
87
In people with advanced cancer, psychedelic drugs like psilocybin, LSD and MDMA may significantly reduce the severity of depression and anxiety symptoms.
Apr 21, 2023
0
22
A research team led by the Nagoya University Graduate School of Medicine has discovered that the stromal cell-derived factor 4 (SDF-4) protein is a reliable cancer marker. As simple blood tests accurately detect the protein, ...
Nov 10, 2023
0
69
Cancer patients are at higher risk of poor outcomes from COVID-19 infection due to their disease and therapies that may weaken the immune system. The development of COVID-19 vaccines has greatly reduced mortality associated ...
Oct 4, 2022
0
48
A fecal microbial transplant—giving a recipient fecal matter from a donor to change the recipient's gut microbial community in the colon—has been a successful last resort therapy for people with recurrent Clostridium ...
Nov 4, 2022
0
63
Patients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than patients who received the previous standard-of-care treatment with either ipilimumab or high-dose ...
Nov 23, 2022
0
4
The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.
Dec 13, 2022
0
4
